Find Paid Research Studies in Anderson, Indiana

Condition:   Cardiovascular Diseases
Interventions:   Drug: Evacetrapib;   Drug: Placebo
Sponsors:   Eli Lilly and Company;   Eli Lilly and Company;   The Cleveland Clinic
Recruiting - verified May 2013

Condition:   Chemotherapy-Induced Nausea and Vomiting
Interventions:   Drug: Fosaprepitant dimeglumine;   Drug: Fosaprepitant Placebo;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone Placebo;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy
Sponsors:   Merck;   Merck
Recruiting - verified May 2013

Condition:   Irritable Bowel Syndrome
Interventions:   Drug: JNJ-27018966;   Other: Placebo Comparator
Sponsors:   Furiex Pharmaceuticals, Inc;   Furiex Pharmaceuticals, Inc
Recruiting - verified May 2013

Condition:   Asthma
Interventions:   Drug: Symbicort pMDI;   Drug: Symbicort pMDI;   Drug: budesonide pMDI;   Drug: budesonide pMDI
Sponsors:   AstraZeneca;   AstraZeneca
Recruiting - verified May 2013

Condition:   Breast Cancer
Interventions:   Radiation: 3-dimensional conformal radiation therapy;   Radiation: accelerated radiation therapy;   Radiation: hypofractionated radiation therapy;   Radiation: intensity-modulated radiation therapy;   Radiation: whole breast irradiation
Sponsors:   Radiation Therapy Oncology Group;   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
Recruiting - verified April 2013

Conditions:   Cancer;   Hematologic Malignancies;   Multiple Myeloma;   Oncology;   Bone Metastases;   Multiple Myeloma Bone Lesions
Interventions:   Drug: Denosumab;   Drug: Zoledronic acid
Sponsors:   Amgen;   Amgen;   Daiichi Sankyo Inc.
Recruiting - verified May 2013

Condition:   Warfarin Therapy
Intervention:   Device: Warfarin GenoSTAT Test
Sponsors:   Iverson Genetic Diagnostics, Inc.;   Iverson Genetic Diagnostics, Inc.
Recruiting - verified May 2013

Condition:   Crohn's Disease
Interventions:   Drug: PF-04236921 SC injection;   Drug: PF-04236921 SC injection;   Drug: PF-04236921 SC injection;   Drug: PF-04236921 SC injection
Sponsors:   Pfizer;   Pfizer
Recruiting - verified May 2013

Conditions:   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer
Interventions:   Drug: doxorubicin hydrochloride;   Drug: docetaxel;   Drug: cyclophosphamide;   Biological: trastuzumab;   Drug: paclitaxel;   Other: laboratory biomarker analysis
Sponsors:   National Cancer Institute (NCI);   National Cancer Institute (NCI)
Recruiting - verified May 2013

Condition:   Herpes Zoster
Interventions:   Biological: V212;   Biological: Placebo
Sponsors:   Merck;   Merck
Recruiting - verified May 2013

Condition:   Lymphoma, Follicular
Interventions:   Biological: Ofatumumab;   Biological: Rituximab
Sponsors:   GlaxoSmithKline;   GlaxoSmithKline
Recruiting - verified April 2013

Conditions:   Pain, Burning;   Pain, Crushing;   Pain, Migratory;   Pain, Radiating;   Pain, Splitting
Interventions:   Drug: JNJ-42160443;   Drug: Placebo
Sponsors:   Janssen Research & Development, LLC;   Janssen Research & Development, LLC
Recruiting - verified April 2013